Lung cancer study IDs new 'epigenomic' target for diagnosis and treatment.

While studying how cancer cells evolve, researchers from MIT and Harvard discovered that the protein RUNX2 plays a key role in promoting the spread of aggressive lung cancer. The finding could guide new diagnostic and treatment strategies in lung cancer, they suggested. [ABSTRACT FROM AUTHOR]